Cetilistat - Investigational Drug for Obesity
Key Data:
Drug (Brand / Generic)
Cetilistat (ATL-962)
Company / Licensee
Alizyme and Takeda Pharmaceutical
Therapy Class
Lipase inhibitor
Product Description
Inhibitor of gastrointestinal lipases
Current Indication
Treatment of obesity in combination with dietary control
Market Sector
Nutrition
Development Status
Phase III started in Japan
